Inhalation OctOber 2017 31
Development for
inhalation and nasal
drug products
Catalent Pharma Solutions can
assist in any stage of development
for inhalation and nasal drug prod-
ucts. Catalent's expertise and expe-
rien ce h ave been successfully
applied to multiple dosage forms.
Catalent Micron Technology's
particle size reduction capabilities
can work to the most stringent
specifications demanded by inhala-
tion formulations. Catalent's inha-
lation services have a track record
of excellence and the company
routinely develops pMDIs, DPIs
and nasal formulations for clients
around the globe.
Catalent Pharma Solutions
US: +1 888 SOLUTION
www.catalent.com
Product development and
compliant manufacture
Hovione offers development and
compliant manufacture of innova-
tive new drugs and niche generic
active pharmaceutical ingredient
(API) products. Hovione also sup-
ports highly potent compounds and
offers proprietary product develop-
ment and licensing opportunities
for drug products. The company
undertakes formulation develop-
ment and clinical supply of final
dosage forms to Phase II. With
strong expertise in pulmonary deliv-
ery, Hovione also offers APIs for
inhala tion, DPI devices and particle
engineer ing services.
Hovione
Portugal: +351 21 982 9000
www.hovione.com
Advertiser index
A
Astech 7
C
Capsugel 1
Copley Scientific 3
H
Hovione 9
M
Management Forum 29
Merxin 11
MSP Cover 4
N
Next Breath 8
P
Proveris Scientific 17
Q
Qualicaps 6
R
RDD 19
Recipharm 10
